Once-Weekly Somatrogon in Pediatric Growth Hormone Deficiency: Real-World Efficacy, Safety, and Quality-of-Life Findings
Once-weekly somatrogon demonstrated efficacy and safety comparable to daily somatropin with stable quality of life and psychosocial outcomes in children with GHD.
Authors
- Ahmet Anık (ORCID: https://orcid.org/0000-0002-7729-7872)
- Tolga Ünüvar (ORCID: https://orcid.org/0000-0002-5517-5030)
- Sebla GÜNEŞ
- Kübra Şen Küçük
- Mustafa Dinçer
- Sercan Öztürk
Institutions
- Pamukkale University (TR)
- Adnan Menderes University (TR)
Publication Details
- Journal
- Journal of Clinical Research in Pediatric Endocrinology
- Published
- 2026-03-16
- DOI
- https://doi.org/10.4274/jcrpe.galenos.2026.2025-11-4
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00